Submit Data |  Help |  Video Tutorials |  News |  Publications |  FTP Download |  REST API |  Citing RGD |  Contact   
Gene: Spink1l (serine peptidase inhibitor, Kazal type 1-like) Rattus norvegicus
Analyze
Symbol: Spink1l
Name: serine peptidase inhibitor, Kazal type 1-like
Description: Predicted to have serine-type endopeptidase inhibitor activity. Involved in aging. Predicted to localize to the extracellular region. Human ortholog(s) of this gene implicated in pancreatitis. Orthologous to human SPINK1 (serine peptidase inhibitor, Kazal type 1).
Type: protein-coding
RefSeq Status: PROVISIONAL
Also known as: calcium transport inhibitor; caltrin; LOC266602; pancreatic secretory trypsin inhibitor II; pancreatic secretory trypsin inhibitor type II (PSTI-II); pancreatic secretory trypsin inhibitor-56; Psti; PSTI-56; PSTI-II; serine peptidase inhibitor, Kazal type 1; serine peptidase inhibitor, Kazal type 3; serine protease inhibitor Kazal-type 1-like; serine protease inhibitor Kazal-type 3; serine protease inhibitor, Kazal type 3; Spink1; Spink3
Orthologs:
No known orthologs. homologs ...
Latest Assembly: Rnor_6.0 - RGSC Genome Assembly v6.0
Position:
Rat AssemblyChrPosition (strand)SourceGenome Browsers
JBrowseNCBIUCSCEnsembl
Rnor_6.01838,177,441 - 38,185,812 (-)NCBIRnor6.0Rnor_6.0rn6Rnor6.0
Rnor_5.01837,834,363 - 37,842,734 (-)NCBIRnor5.0Rnor_5.0rn5Rnor5.0
RGSC_v3.41837,090,934 - 37,099,835 (-)NCBIRGSC3.4rn4RGSC3.4
Cytogenetic Map18q11NCBI
JBrowse: View Region in Genome Browser (JBrowse)
Model


Gene Ontology Annotations
References - curated
References - uncurated

Genomics

QTLs in Region (Rnor_6.0)
miRNA Target Status

Sequence

Nucleotide Sequences
Protein Sequences
Transcriptome
Promoters

Strain Variation

Strain Sequence Variants (Rnor 5.0)

Additional Information

External Database Links
Nomenclature History
 
More on Spink1l
Alliance Gene
NCBI Gene
Ensembl Gene
JBrowse: rn5 rn6
NCBI Genome Data Viewer

CRRD Object Information
CRRD ID: 708468
Created: 2003-09-23
Species: Rattus norvegicus
Last Modified: 2019-04-12
Status: ACTIVE



NHLBI Logo

RGD is funded by grant HL64541 from the National Heart, Lung, and Blood Institute on behalf of the NIH.